Related Experiment Video
Updated: May 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Antiplatelet and anticoagulation medications and the surgical patient
Brian K Yorkgitis1, Christina Ruggia-Check2, Jay E Dujon3
1Department of Surgery, Temple University Hospital, 3401 North Broad Street, Suite 450, Philadelphia, PA 19140, USA.
Insights
Surgeons must understand how antiplatelet agents and anticoagulants affect patient coagulation. This review details the pharmacology and reversal strategies for medications impacting surgical patients.
Area of Science:
- Pharmacology
- Surgical Care
- Coagulation Science
Background:
- Acute coronary syndrome and atrial fibrillation affect millions, necessitating antiplatelet and anticoagulant use.
- These medications are crucial for treating cardiovascular conditions but impact surgical patient management.
- Understanding drug pharmacology is vital for surgeons caring for patients on coagulation-altering medications.
Purpose of the Study:
- To review the pharmacology of agents affecting blood coagulation.
- To provide surgeons with essential knowledge for managing patients on these medications.
- To discuss reversal strategies for common anticoagulant and antiplatelet drugs.
Main Methods:
- A comprehensive literature review was conducted.
- Recent studies on pharmacologic agents affecting coagulation were analyzed.
- Information on drug properties and reversal methods was compiled.
Main Results:
- Various medications that alter normal coagulation were identified and reviewed.
- Key pharmacologic properties of these agents were detailed.
- Effective reversal strategies for different drug classes were discussed.
Conclusions:
- Numerous medications impact patient coagulation, including novel agents.
- This review equips surgeons with critical knowledge for patient care.
- Understanding these drugs enhances surgical outcomes for patients on antithrombotics.
Background:
Acute coronary syndrome affects more than 750,000 Americans per year, and antiplatelet agents are the cornerstones of treatment. Atrial fibrillation affects 2.4 million patients in the United States, and venous thromboembolism occurs in 1 to 2 per 1,000 adults per year. Anticoagulants are commonly prescribed to affected patients. Surgeons are commonly called upon to care for patients taking medications that affect normal coagulation. It is important that the surgical community has a fundamental understanding of these agents' pharmacology, which may impact patients' clinical course.
Methods:
A review of recent literature on pharmacologic agents that affect coagulation was performed.
Results:
A number of medications that alter normal coagulation were reviewed in this article including their pharmacologic properties and reversal strategies.
Conclusions:
There are a variety of medications that affect a patient's coagulation ability, including many newer agents on the market. This review provides surgeons with the knowledge needed to assist in caring for individuals receiving these drugs.
More Related Videos
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Aneurysm IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

